trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Screening methods can accurately detect colon cancer in asymptomatic populations.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
11 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that screening methods can accurately detect colon cancer in asymptomatic populations?

Yes. Multiple clinical references and peer-reviewed studies establish that various screening methods—such as colonoscopy, fecal immunochemical tests, and stool DNA tests—are widely recommended and capable of accurately detecting colon cancer and precancerous lesions in asymptomatic populations.

Verdict: SUPPORTED · 11 sources for, 0 against · Last checked

The analysis

Judged against the evidence record for claims of this kind.

Evidence for · 11
Reference article covering this claim directly
Get citation
Wikipedia: Colorectal cancer. (n.d.). Wikipedia. https://en.wikipedia.org/wiki/Colorectal_cancer

See more details
More for · 10
Reference article covering this claim directly
Get citation
Wikipedia: Cancer screening. (n.d.). Wikipedia. https://en.wikipedia.org/wiki/Cancer_screening

2016
Reviews non-invasive and gold standard screening methods to accurately detect lesions in average-risk adults.
Get citation
OpenAIRE: A Review of Colorectal Cancer Detection Modalities, Stool DNA, and Fecal Immunochemistry Testing in Adults Over the Age of 50. (2016). OpenAIRE. https://doi.org/10.7759/cureus.931

2023
Details that screening programs using occult bleeding and colonoscopy effectively detect colon cancer early.
Get citation
OpenAIRE: Vývoj diagnostických metod kolorektálního karcinomu. (2023). OpenAIRE. https://explore.openaire.eu/

2024
Mentions breath VOC analysis accuracy for various cancers including colon cancer, but remains a novel frontier.
Get citation
OpenAIRE: Volatile organic compounds: A promising new frontier for cancer screening. (2024). OpenAIRE. https://doi.org/10.36922/td.2061

2016
Evaluates FIT and M2-PK in asymptomatic subjects to detect early colorectal cancer successfully.
Get citation
Caviglia, G., Cabianca, L., Fagoonee, S., & Gili, F. (2016). Colorectal cancer detection in an asymptomatic population: fecal immunochemical test for hemoglobin vs. fecal M2-type pyruvate kinase. peer-reviewed literature. https://doi.org/10.11613/BM.2016.012

2023
Compares screening uptake and diagnostic yield of colonoscopy versus FIT in asymptomatic high-risk individuals.
Get citation
González-López, N., Quintero, E., Gimeno-García, A. Z., Bujanda, L., Banales, J., Cubiella, J., Salve-Bouzo, M., Herrero-Rivas, J. M., Cid-Delgado, E., Álvarez-Sánchez, V., Ledo-Rodríguez, A., de-Castro-Parga, M. L., Fernández-Poceiro, R., Sanromán-Álvarez, L., Santiago-Garcia, J., Herreros-de-Tejada, A., Ocaña-Bombardo, T., Balaguer, F., Rodríguez-Soler, M., Jover, R., Ponce, M., Álvarez-Urturi, C., Bessa, X., Roncalés, M., Sopeña, F., Lanas, Á., Nicolás-Pérez, D., Adrián-de-Ganzo, Z., Carrillo-Palau, M., & González-Dávila, E. (2023). Screening uptake of colonoscopy versus fecal immunochemical testing in first-degree relatives of patients with non-syndromic colorectal cancer: A multicenter, open-label, parallel-group, randomized trial (ParCoFit study). peer-reviewed literature. https://doi.org/10.1371/journal.pmed.1004298

2020
Demonstrates the short-term efficacy of a population-based pilot screening program for asymptomatic individuals.
Get citation
Rutka, M., Bor, R., Molnár, T., Farkas, K., Pigniczki, D., Fábián, A., Győrffy, M., Bálint, A., Milassin, Á., Szűcs, M., Tiszlavicz, L., Nagy, F., & Szepes, Z. (2020). Efficacy of the population-based pilot colorectal cancer screening, Csongrád county, Hungary, 2015. peer-reviewed literature. https://doi.org/10.3906/sag-1908-79

2026
Validates predictive models and screening for advanced colorectal neoplasia in asymptomatic individuals.
Get citation
Y, L., Y, L., Y, F., B, L., W, Y., N, Z., & Y, L. (2026). Derivation and Validation of a Predictive Model for Advanced Colorectal Neoplasia Among Average-Risk Adults in China.. peer-reviewed literature. https://doi.org/10.1002/ijc.70533

2026
Evaluates blood-based ctDNA assays for early detection in asymptomatic populations, noting mixed sensitivities.
Get citation
CL, K., MW, R., J, K., IS, P., & C, T. (2026). Blood-Based Circulating Tumor DNA Assays for Early Colorectal Cancer Detection: A Systematic Review of Performance in Asymptomatic Screening Populations.. peer-reviewed literature. https://doi.org/10.1002/ijc.70498

2026
Examines risk stratification scores for detecting advanced colorectal neoplasia in asymptomatic patients via colonoscopy.
Get citation
DT, Q., NTH, V., HTT, T., HND, T., DTA, N., TDA, P., DQ, N., & T, H. (2026). Comparing the Asia-Pacific Colorectal Screening and adjusted Asia-Pacific Colorectal Screening scores for risk stratification of advanced colorectal neoplasia in asymptomatic Vietnamese: a cross-sectional study.. peer-reviewed literature. https://doi.org/10.1136/bmjopen-2025-102941

Related receipts

What does the evidence say?

Judged against the evidence record for claims of this kind.

Receipt History
first checked05 Aug 2026
judged → SUPPORTED · 8205 Aug 2026
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work